Početna › Rak mjehura › Washington
Kliničke studije za Rak mjehura u državi Washington
25 studija za Rak mjehura traži sudionike na lokacijama u državi Washington.
Gradovi u državi Washington
Službeni tekst studije (engleski)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- i još 19
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- University of Washington - Fred Hutchinson Cancer Center ( Site 0100), Seattle
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06833073Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-First Hill, Seattle
- University of Washington Medical Center - Montlake, Seattle
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07061964Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07667335Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Valley Medical Center, Renton
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT03866382Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- Eye Associates Northwest - Edmonds Clinic, Edmonds
- Eye Associates Northwest - Kirkland Clinic, Kirkland
- Eye Associates Northwest - Ballard Clinic and Surgery Center, Seattle
- i još 6
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07421700A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Swedish Cancer Institute, Seattle
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07277413A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
- Fred Hutchinson Cancer Research Center ( Site 0787), Seattle
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07419295Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
- University of Washington Fred Hutchinson Cancer Center, Seattle
U tijeku regrutacijaFaza 1/2
Od 18 do 99 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT06814496A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
- Fred Hutch/University of Washington Cancer Consortium, Seattle
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 10. ruj 2026. · NCT06040762Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Spokane Urology, Spokane
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT06567743The Vanguard Study: Testing a New Way to Screen for Cancer
- Madigan Army Medical Center, Tacoma
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 45 do 75 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT06995898Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial
- Fred Hutch/University of Washington Cancer Consortium, Seattle
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 25. kol 2026. · NCT07579195Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Spokane Urology, Spokane
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 24. kol 2026. · NCT05951179Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Muškarci · Ažurirano 6. kol 2026. · NCT01050504Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 31. srp 2026. · NCT07225127Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Local Institution - 0200, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center - Montlake, Seattle
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 29. srp 2026. · NCT07106762A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- University of Washington School of Medicine, Seattle
U tijeku regrutacijaFaza 2
Od 8 godina i više · Oba spola · Ažurirano 27. srp 2026. · NCT05503797An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
- Research Site, Seattle
- Research Site, Tacoma
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. srp 2026. · NCT07720284A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- Harborview Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 22. srp 2026. · NCT04879329Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial
- Fred Hutch/University of Washington Cancer Consortium, Seattle
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 6. srp 2026. · NCT07302230A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Northwest Medical Specialities. PLLC, Bonney Lake
- Swedish Cancer Institute - Edmonds Campus, Edmonds
- Swedish Cancer Institute Edmonds Campus, Edmonds
- i još 9
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 6. srp 2026. · NCT04389632A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Fred Hutchinson Cancer Center, Seattle
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 13. velj 2026. · NCT06778863Blue Light Cystoscopy With Cysview® Registry
- University of Washington Medicine, Seattle
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 18. pro 2025. · NCT02660645SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Seattle
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.